Konstandin et al. used a genetic approach to investigate the role of fibronectin in the pressure-overloaded heart, where fibronectin removal reduces cardiomyocyte hypertrophy, delays the onset of heart failure, and increases survival [134]. The gene discussed is FN1; the disease is heart failure.